Hangzhou Tigermed Consulting Co., Ltd.
SZSE:300347.SZ
Overview | Financials
Company Name | Hangzhou Tigermed Consulting Co., Ltd. |
Symbol | 300347.SZ |
Currency | CNY |
Price | 57.41 |
Market Cap | 47,125,745,634 |
Dividend Yield | 0.97% |
52-week-range | 55.94 - 130 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D. |
Website | https://www.tigermed.net |
An error occurred while fetching data.
About Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD